Comparative Analysis of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Trials - Summary - MDSpire

Comparative Analysis of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Trials

  • By

  • Felipe Pereira Garrido Pazos

  • Rafael Matos Vieira Gordilho

  • Eduardo de Oliveira Novelli

  • Luiz Guilherme Lima Santana

  • Maria da Conceição Cavalcanti de Figueiredo Vilaboim

  • Breno Santos Matos de Magalhães

  • Maria Luisa França Lessa

  • Pedro Henrique Matos Oliveira

  • Marcelo Falcão

  • April 29, 2026

  • 0 min

Share

Objective:

To compare Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) regarding continuous metabolic markers (e.g., HbA1c, lipid profiles) and remission of cardiometabolic comorbidities across different follow-up periods.

Key Findings:
  • 24 studies met eligibility criteria for analysis.
  • RYGB showed superior outcomes in certain metabolic markers (e.g., HbA1c, triglycerides) compared to SG.
  • Long-term follow-up indicated variability in T2DM remission rates between the two procedures.
Interpretation:

RYGB may offer better long-term metabolic health benefits compared to SG, but results vary based on specific outcomes (e.g., T2DM remission) and follow-up duration.

Limitations:
  • Heterogeneity among studies regarding patient populations and outcomes, which may affect generalizability.
  • Limited long-term data for some outcomes, potentially impacting the robustness of conclusions.
Conclusion:

Both RYGB and SG are effective for obesity management, but RYGB may have advantages in certain cardiometabolic outcomes over time.

Original Source(s)

Related Content